Promising vaccine may provide new treatment option for patients with HER2-positive ca

[News]

Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.

More... (https://www.news-medical.net/news/20180930/Promising-vaccine-may-provide-new-treatment-option-for-patients-with-HER2-positive-cancers.aspx)